FDA official logo
GSRS logo
PFDA official logo

FARLETUZUMAB

  • UNII: 2O09BG0OWA
  • Preferred Substance Name: FARLETUZUMAB

  • 896723-44-7
  • FARLETUZUMAB [INN]
  • FARLETUZUMAB [JAN]
  • FARLETUZUMAB [MART.]
  • FARLETUZUMAB [USAN]
  • FARLETUZUMAB [WHO-DD]
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR FR-.ALPHA. (FOLATE RECEPTOR .ALPHA.)) (HUMAN-MOUSE MONOCLONAL MORAB-003 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MORAB-003 .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR FR-.ALPHA. (FOLATE RECEPTOR .ALPHA.)) (HUMAN-MOUSE MONOCLONAL MORAB-003 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL MORAB-003 .KAPPA.-CHAIN, DIMER
  • MORAB-003

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.